RU99100084A - Применение ингибиторов клеточного натрий-водородного обмена для получения лекарственного средства для нормализации уровня липидов сыворотки - Google Patents

Применение ингибиторов клеточного натрий-водородного обмена для получения лекарственного средства для нормализации уровня липидов сыворотки

Info

Publication number
RU99100084A
RU99100084A RU99100084/14A RU99100084A RU99100084A RU 99100084 A RU99100084 A RU 99100084A RU 99100084/14 A RU99100084/14 A RU 99100084/14A RU 99100084 A RU99100084 A RU 99100084A RU 99100084 A RU99100084 A RU 99100084A
Authority
RU
Russia
Prior art keywords
normalization
application
serum lipids
metabolism inhibitors
cellular sodium
Prior art date
Application number
RU99100084/14A
Other languages
English (en)
Other versions
RU2211032C2 (ru
Inventor
Ханс Йохен Ланг
Ханс-Вилли ЯНСЕН
Ян-Роберт Шварк
Хайнц-Вернер КЛЕЕМАНН
Оливер Юнг
Ханс-Людвиг ШЕФЕР
Вольфганг Линц
Вернер Крамер
Бернвард Шелькенс
Ойген Фальк
Original Assignee
Хехст Акциенгезелльшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19622222A external-priority patent/DE19622222A1/de
Priority claimed from DE19712636A external-priority patent/DE19712636A1/de
Application filed by Хехст Акциенгезелльшафт filed Critical Хехст Акциенгезелльшафт
Publication of RU99100084A publication Critical patent/RU99100084A/ru
Application granted granted Critical
Publication of RU2211032C2 publication Critical patent/RU2211032C2/ru

Links

Images

Claims (1)

  1. Текст формулы заявки в факсимильном виде (см. чертижи).
RU99100084/14A 1996-06-03 1997-05-20 Применение ингибиторов клеточного натрий-водородного обмена для получения лекарственного средства для нормализации уровня липидов сыворотки RU2211032C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19622222.2 1996-06-03
DE19622222A DE19622222A1 (de) 1996-06-03 1996-06-03 Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide
DE19712636A DE19712636A1 (de) 1997-03-26 1997-03-26 Verwendung von Inhibitoren des zellulären Na+/H+Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide
DE19712636.7 1997-03-26

Publications (2)

Publication Number Publication Date
RU99100084A true RU99100084A (ru) 2000-11-10
RU2211032C2 RU2211032C2 (ru) 2003-08-27

Family

ID=26026256

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99100084/14A RU2211032C2 (ru) 1996-06-03 1997-05-20 Применение ингибиторов клеточного натрий-водородного обмена для получения лекарственного средства для нормализации уровня липидов сыворотки

Country Status (23)

Country Link
EP (1) EP0918515B1 (ru)
JP (1) JP4527811B2 (ru)
KR (1) KR100511711B1 (ru)
CN (1) CN1221339A (ru)
AR (1) AR007353A1 (ru)
AT (1) ATE293965T1 (ru)
AU (1) AU722166B2 (ru)
BR (1) BR9709516A (ru)
CA (1) CA2257299A1 (ru)
DE (2) DE19622222A1 (ru)
DK (1) DK0918515T3 (ru)
ES (1) ES2241049T3 (ru)
IL (1) IL126935A0 (ru)
NO (1) NO985480L (ru)
NZ (1) NZ333095A (ru)
PL (1) PL189950B1 (ru)
PT (1) PT918515E (ru)
RU (1) RU2211032C2 (ru)
SI (1) SI0918515T1 (ru)
SK (1) SK165898A3 (ru)
TR (1) TR199802505T2 (ru)
WO (1) WO1997046226A2 (ru)
ZA (1) ZA974828B (ru)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
US6160134A (en) * 1997-12-24 2000-12-12 Bristol-Myers Squibb Co. Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
DE19859727A1 (de) * 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
CA2370607A1 (en) 1999-04-23 2000-11-02 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
DE19945302A1 (de) * 1999-09-22 2001-03-29 Merck Patent Gmbh Biphenylderivate als NHE-3-Inhibitoren
US6423705B1 (en) 2001-01-25 2002-07-23 Pfizer Inc. Combination therapy
AU2002348276A1 (en) 2001-11-16 2003-06-10 Bristol-Myers Squibb Company Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
US7230007B2 (en) 2003-06-12 2007-06-12 Sanofi-Aventis Deutschland Gmbh Derivatives of 3-(Guanidinocarbonyl) heterocycle, methods of preparation and intermediates thereof, their use as medicaments, and pharmaceutical compositions therefrom
FR2856062B1 (fr) * 2003-06-12 2005-11-11 Aventis Pharma Sa Derives 3-guanidinocarbonyl-heterocycle, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
EP1646371A4 (en) * 2003-06-26 2010-09-22 Biotron Ltd ANTIVIRAL COMPOSITIONS AND METHODS
US7371759B2 (en) 2003-09-25 2008-05-13 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
US7420059B2 (en) 2003-11-20 2008-09-02 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
US7572805B2 (en) 2004-07-14 2009-08-11 Bristol-Myers Squibb Company Pyrrolo(oxo)isoquinolines as 5HT ligands
US7517991B2 (en) 2004-10-12 2009-04-14 Bristol-Myers Squibb Company N-sulfonylpiperidine cannabinoid receptor 1 antagonists
US7314882B2 (en) 2005-01-12 2008-01-01 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
WO2006076569A2 (en) 2005-01-12 2006-07-20 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
US20060160850A1 (en) 2005-01-18 2006-07-20 Chongqing Sun Bicyclic heterocycles as cannabinoid receptor modulators
ATE421518T1 (de) 2005-02-10 2009-02-15 Bristol Myers Squibb Co Dihydrochinazolinone als 5ht-modulatoren
US7452892B2 (en) 2005-06-17 2008-11-18 Bristol-Myers Squibb Company Triazolopyrimidine cannabinoid receptor 1 antagonists
US7632837B2 (en) 2005-06-17 2009-12-15 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid-1 receptor modulators
TW200726765A (en) 2005-06-17 2007-07-16 Bristol Myers Squibb Co Triazolopyridine cannabinoid receptor 1 antagonists
US7317012B2 (en) 2005-06-17 2008-01-08 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoind-1 receptor modulators
US7629342B2 (en) 2005-06-17 2009-12-08 Bristol-Myers Squibb Company Azabicyclic heterocycles as cannabinoid receptor modulators
US7795436B2 (en) 2005-08-24 2010-09-14 Bristol-Myers Squibb Company Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists
AR056155A1 (es) 2005-10-26 2007-09-19 Bristol Myers Squibb Co Antagonistas del receptor 1 de la hormona de concentracion de melanina no basica
US7553836B2 (en) 2006-02-06 2009-06-30 Bristol-Myers Squibb Company Melanin concentrating hormone receptor-1 antagonists
US20090011994A1 (en) 2007-07-06 2009-01-08 Bristol-Myers Squibb Company Non-basic melanin concentrating hormone receptor-1 antagonists and methods
PE20091928A1 (es) 2008-05-29 2009-12-31 Bristol Myers Squibb Co Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos
US10517839B2 (en) 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
AU2010229653A1 (en) 2009-03-27 2011-10-20 Astrazeneca Ab Methods for preventing major adverse cardiovascular events with DPP-IV inhibitors
AU2011210765A1 (en) 2010-01-28 2012-09-13 President And Fellows Of Harvard College Compositions and methods for enhancing proteasome activity
ES2724531T3 (es) 2011-05-12 2019-09-11 Proteostasis Therapeutics Inc Reguladores de proteostasis
EP2892897A1 (en) 2012-09-05 2015-07-15 Bristol-Myers Squibb Company Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
EP2892896B1 (en) 2012-09-05 2016-06-29 Bristol-Myers Squibb Company Pyrrolone or pyrrolidinone melanin concentrating hormore receptor-1 antagonists
WO2014116228A1 (en) 2013-01-25 2014-07-31 President And Fellows Of Harvard College Usp14 inhibitors for treating or preventing viral infections
WO2015073528A1 (en) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds
EP3823631A1 (en) 2018-07-19 2021-05-26 Astrazeneca AB Methods of treating hfpef employing dapagliflozin and compositions comprising the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110817A (en) * 1988-10-21 1992-05-05 Beyer Jr Karl H Method for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals
US4920123A (en) * 1988-10-21 1990-04-24 Beyer Jr Karl H Method for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals
AU7316591A (en) * 1990-02-28 1991-09-18 Upjohn Company, The Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
ATE157351T1 (de) * 1993-02-20 1997-09-15 Hoechst Ag Substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament, als inhibitoren des zellulären na+/h+-austauschs oder als diagnostikum sowie sie enthaltendes medikament
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4325822A1 (de) * 1993-07-31 1995-02-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
IL114670A0 (en) * 1994-08-05 1995-11-27 Fujisawa Pharmaceutical Co Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof

Similar Documents

Publication Publication Date Title
RU99100084A (ru) Применение ингибиторов клеточного натрий-водородного обмена для получения лекарственного средства для нормализации уровня липидов сыворотки
DE69528230D1 (de) Lautsprechereinbau
IT1290987B1 (it) Integrazione elettronica in cassette di servizi.
RU95121619A (ru) Средство для фитокоррекции
ITBS940060A0 (it) Distributore automatico di giornali riviste e simili
RU98116473A (ru) Применение ингибиторов натрий-водородного обмена для получения лекарственного средства в целях уменьшения нежелательных воздействий веществ на сердце
KR950027025U (ko) 앨범
KR960010267U (ko) 앨범
ATE176632T1 (de) Albumblatt
ES1027646Y (es) Estuche portatil para catalogos y similares.
BR9403036A (pt) Cobertura para alto-falantes.
ITPA950012V0 (it) Svelto in tavola
KR950027024U (ko) 앨범
ES1026720Y (es) Cartela para estanterias.
KR960013645U (ko) 두께유지기능을 갖는 앨범대지
KR950027028U (ko) 앨범용 마트지
ES1024856Y (es) Soporte para conducciones aereas.
FI964282A (fi) Jäähdytysaineseos
IT233562Y1 (it) Album per fotografie.
BR7402362U (pt) Conjunto para refresco
ES1033020Y (es) Carcasa empotrable para altavoces.
ES1026971Y (es) Dispositivo magnetico para soporte de libretas.
UA165U (uk) Пристрій для знаходження сторінок в довідковому виданні
ITVI940019V0 (it) Dispositivo di presentazione di spazi pubblicitari.
ITVI940070A0 (it) Dispositivo di presentazione di spazi pubblicitari.